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OBJECTIVES: This study sought to determine the level of agreement between behavioral and multidimensional pain
assessment scales in term newborn infants submitted to an acute nociceptive stimulus.
METHODS: This cross-sectional study was performed on 400 healthy term newborns who received an intramuscular
injection of vitamin K during the first 6 hours of life. Two behavioral pain scales (the Neonatal Facial Coding System
and the Behavioral Indicators of Infant Pain) and one multidimensional tool (the Premature Infant Pain Profile) were
applied by a single observer before the procedure, during cleansing, during injection and two minutes after
injection. The Cochran Q, McNemar and kappa tests were used to compare the presence and degree of agreement
between the three scales. The Hotelling T2 test was used to compare the groups of newborns for which the scales
showed agreement or disagreement. A generalized linear regression was used to compare the results of the
Neonatal Facial Coding System and the Behavioral Indicators of Infant Pain across the four study time points.
RESULTS: The neonates studied had a gestational age of 39¡1 weeks, a birth weight of 3169¡316 g and and
postnatal age of 67¡45 minutes. During the stimulus procedure, 80% of the newborns exhibited pain behaviors
according to the Neonatal Facial Coding System and the Behavioral Indicators of Infant Pain, and 70% experienced
pain according to the Premature Infant Pain Profile (p,0.001). The frequencies of the detection of pain using the
Behavioral Indicators of Infant Pain and the Neonatal Facial Coding System were similar. The characteristics of the
neonates were not associated with the level of agreement between the scales.
CONCLUSION: The Neonatal Facial Coding System and the Behavioral Indicators of Infant Pain behavioral scales are
more sensitive for the identification of pain in healthy term newborn infants than the multidimensional Premature
Infant Pain Profile scale.
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INTRODUCTION
Starting at birth, critically ill newborn babies undergo
repetitive, painful stimuli as part of diagnostic and ther-
apeutic procedures that are necessary for their survival (1). In
the neonatal intensive care unit (NICU) during the first two
weeks after birth, newborns are exposed to approximately 16
invasive procedures per day, of which only one-third are
completed under analgesia (2). The cardiovascular and
respiratory effects associated with the endocrine-metabolic
response to acute nociceptive stimuli may increase neonatal
morbidity and mortality (3). The under-treatment of pain can
trigger behavioral responses in the newborn and may have
long-lasting effects on the nociceptive system that result in an
altered processing of pain and stress (4,5) and an increased
susceptibility to psychosomatic (6) and psychiatric (7)
changes during childhood and adolescence.
It is widely acknowledged that the application of a valid
and reliable tool to assess pain in newborns is essential for
proper diagnosis, which is the first step towards effective
treatment (8). However, the assessment of pain in newborns
represents a great challenge. Two of the major limitations to
achieving pain relief in clinical practice include the lack of a
reliable biomarker and the absence of a gold standard scale
that is capable of measuring the intensity of the pain, the
need for treatment and the effectiveness of the intervention.
Although there are more than 30 scales for assessing pain in
newborns, no specific scale has demonstrated superiority.
Most of these instruments rely on physiological and
behavioral parameters, which are indirect responses to the
painful stimulus.
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Physiological parameters, including heart rate, respira-
tory rate, oxygen saturation, intracranial and blood pres-
sure, among others, have the advantage of being objective
measures, but changes in these parameters are not specific
to painful phenomenon (9). Behavioral responses are the
language used by infants to communicate with their
caregivers, but their operational definitions are sometimes
subjective, diminishing the sensitivity and specificity of
these parameters as indicators of pain (10). The main
behavioral responses to pain in preverbal infants are crying
and body and facial movements. The facial expression
reflects the painful experience effectively and specifically
(11,12); indeed, facial movements correlate best with cortical
activity during a painful stimulus in comparison with
physiologic indicators as demonstrated by Slater et al. in a
study using near-infrared spectroscopy following a clinical
required nociceptive stimulus (13). Facial actions used as
pain indicators are lowering of the brows, squeezing the
eyes shut, deepening of the nasolabial furrow, opening of
the lips, stretching of the mouth, tightening the tong,
pursing of the lips and quivering of the chi (10,11); different
neonatal pain scales are based on these indicators. Similarly,
body movements are behavioral indicators of pain, and
some authors have suggested that hand movements,
especially the presence of finger splay and fisting, are
associated specifically with acute stress and are more
frequently displayed in the infant with acute pain (14).
The complexity of pain suggests that the use of multi-
dimensional pain scales would improve the pain assess-
ment. However, the dissociation that occurs between
behavioral and physiological indicators of pain could hinder
the recognition of newborns that require analgesic treatment
(15). The dissociation of responses to pain displayed by the
newborn can be observed when the patient exhibits a
behavior that is consistent with pain, although the physio-
logical indicators suggest that the intensity of the nocicep-
tive stimulus is not sufficient to trigger responses in
different organs and systems. This phenomenon may be
related to problems in the integrity of the central and
peripheral nervous system that are associated with the
clinical condition of the newborn and to the immaturity of
the nociceptive neonatal pain pathways (16,17).
In this context, different neonatal pain evaluation tools
available at the clinical setting may lead to heterogeneous
results, which could contribute to the difficulty in recogniz-
ing the need for pain relief in newborn infants. The aim of
the present study was to determine the best strategy for the
assessment of pain in healthy term newborns during the
first hours of life by comparing the frequency of the
detection of pain with uni-dimensional and multi-dimen-
sional scales during an intramuscular injection of vitamin K.
MATERIAL AND METHODS
A cross-sectional study with prospective data collection
was performed. The research methods followed the guide-
lines and standards for research on human subjects of the
National Health Council and were initiated with the
approval of the Ethics Committee on Research of the
Federal University of Sa˜o Paulo and Padre Albino Hospital.
All patients fulfilled the following inclusion criteria:
written informed consent; gestational age between 370/7
and 416/7 weeks, as determined using the best obstetric
estimate; appropriate weight for gestational age (18); and an
Apgar score .7 at the first and fifth minutes of life without
the need for any resuscitation procedures in the delivery
room. Patients were excluded from the study if their
mothers had used opioids during pregnancy, labor or
delivery or had received general anesthesia for the delivery.
In addition, patients with early neonatal morbidities were
excluded, as were those patients with major congenital
malformations and/or chromosomal syndromes. Finally,
neonates born using assisted vaginal delivery or those who
experienced a birth injury were also excluded from the
study because such conditions would introduce a con-
founding variable related to the experience of pain.
In the first hour of life, each eligible newborn was placed
in an incubator and was naked except for a diaper. After
placing an oximeter on his/her right foot, the newborn
remained at rest in the supine position, without any
handling, for 8 minutes. Immediately following this period,
the first pain assessment was performed (T0 or Rest). Two
minutes later, a nurse cleaned the lateral left thigh of the
newborn using a 70% alcohol swab at room temperature for
30 seconds. After cleansing, another pain assessment was
performed (T1 or Cleansing). One minute after cleansing,
the same nurse administered 1 mg of vitamin K intramus-
cularly in the same location using a 1-mL syringe and a
13x4.5-mm needle. During insertion of the needle, the third
pain assessment was performed (T2 or Injection). After mild
compression with dry cotton, the newborn remained at rest
in the supine position for 2 minutes, after which time
another pain assessment was conducted (T3 or Recovery).
The infants were assessed in real time at the bedside
without filming. Before starting the study, specific training
with respect to the administration of vitamin K was given
by the head nurse to all of the nurses to standardize the
procedure. Newborn infants submitted to routine vitamin K
injection after birth did not receive analgesia, as per hospital
standards at that time.
The pain assessment was performed by evaluating the
following scales: the Neonatal Facial Coding System
(NFCS), in which pain represented a NFCS score .3
(11,12,19), and the Behavioral Indicators of Infant Pain
(BIIP), which defined the presence of pain as a BIIP score$5
(20,21). The same observer also assessed the items that make
up the multidimensional Premature Infant Pain Profile
(PIPP), in which the presence of pain was defined as a PIPP
score $7 (22). The heart rate and oxygen saturation of the
newborns were measured using a pulse oximeter. The
translation of the text describing the BIIP was performed by
the last author (RG), who had also translated the NFCS and
PIPP into Portuguese in 1991 and 1997, respectively.
Because all scales were objectively applied by a single
observer, the heterogeneity in evaluating the same items in
different patients was limited. A pilot study of 50 full-term
newborns infants was conducted, and the NFCS, BIIP and
PIPP were simultaneously scored during vitamin K injection
by the first author as well as a neonatal attending with
expertise in pain assessment. This pilot study showed 90-
95% agreement between the raters for the individual items
of the three scales and aided in the design of a functional
flow sheet that would allow a single observer to collect all of
the necessary data. A scoring sheet adapted from Hoslti et
al. (20) displayed all individual items to be checked as
present or absent in the study periods and included space
for the heart rate and oxygen saturation values. The
observer was unaware of the PIPP, BIIP and NFCS scores
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during the observation of the infants. The full scores were
given for each scale after the collection of all data.
The sample size was calculated for a type I error of 5%, a
sample power of 90% and a two-tailed hypothesis, assum-
ing that the NFCS would identify 90% of the term infants
who experienced pain during acute nociceptive stimulation
and that the PIPP and BIIP scales could identify 80% of the
term infants who experienced pain in response to the same
acute painful stimulus. Given these assumptions, 393
newborns had to be examined simultaneously using the
three scales for statistically significant results to be obtained.
The Q and Cochran tests were used to determine the level
of agreement between the three rating scales with respect to
the presence of pain during the injection (T2), and the
McNemar test was then applied to determine the level of
agreement between pairs of the scales (two by two).
Additionally, a kappa analysis was performed to determine
the degree of concordance between the scales with respect
to the presence or absence of pain. To compare those
newborns for whom the three scales were in agreement
concerning the presence or absence of pain to those
newborns for whom disagreement was observed between
the scales, the Hotelling T2 test and Bonferroni confidence
intervals were applied. Finally, the NFCS and BIIP scores
obtained for the four study periods (T0, T1, T2, and T3) were
compared using generalized linear regression models with
the Bernoulli distribution.
RESULTS
Four hundred newborns (200 males and 200 females) with
the following characteristics were enrolled in the study:
gestational age of 39¡1 weeks, birth weight of 3169¡316 g,
postnatal age of 67¡45 minutes and median Apgar scores
in the first and fifth minutes of life of 9 and 10, respectively.
Sixty-five percent of the infants were delivered by cesarean
section. In the delivery room, 100% of the infants were
placed under a radiant warmer. According to hospital
routine at the time of data collection, none of the newborns
was breastfed or received skin-to-skin contact with the
mother in the delivery room.
The NFCS, BIIP and PIPP scores are presented in Table 1.
The PIPP scores were obtained by comparing the T2
(injection) and T0 (rest) time points. Measurements were
not obtained for three patients due to the poor quality of the
plethysmographic waves captured by the pulse oximeter.
According to the NFCS and BIIP scales, 3-4% of the
newborns exhibited pain-related behaviors in the resting
state. During cleansing, this frequency increased to 15% and
reached approximately 80% during the injection. Two
minutes after the injection, 10% of the newborns still
exhibited pain-related behaviors. According to the PIPP,
70% of the newborns had scores that suggested the presence
of pain during the injection of vitamin K.
To determine the level of agreement or disagreement
between the pain scales during the injection, the number of
neonates who exceeded the cutoff score associated with
pain using all three tools (agreement) was compared to the
frequency at which only one or two of the three scales were
indicative of pain (disagreement). Overall, agreement was
observed in 85% of the evaluated newborns. In 59 (15%)
patients, only two scales showed the presence of pain
during the intramuscular injection. Of these 59 patients, 45
(76%) had NFCS and BIIP scores that were suggestive of
pain and PIPP scores that were below the pain cutoff
(Table 2). The Cochran Q test revealed significant disagree-
ment between the three scales (p,0.001).
The Bonferroni confidence interval (CI) was used to
determine whether the characteristics of the neonates were
associated with the disagreement observed between the
three pain scales. Therefore, the patients were grouped
according to number of scales whose results agreed with
respect to the presence of pain during the intramuscular
injection (three scales in agreement, n = 338; two scales in
agreement, n = 59), and the results are shown in Table 3. The
Hotelling T2 test demonstrated that there were no differ-
ences between the group of newborns for whom the three
scales were in agreement regarding the presence of pain
during T2 and the group of newborns with disagreement for
at least one scale (p= 0.83), which indicated that none of the
studied neonatal characteristics was associated with the
scales used to assess pain.
In view of the disagreement between the assessment tools
employed during the painful procedure, we attempted to
identify the differences between the scales using the
following pairwise comparisons at the time of injection:
NFCS vs. PIPP, BIIP vs. PIPP and NFCS vs. BIIP. The
comparison of the NFCS to the PIPP with respect to the
presence of pain using the McNemar test revealed a
Table 1 - Pain scale scores (NFCS, BIIP and PIPP) for the 4 studied time periods.
Rest Cleansing Injection Recovery
NFCS Mean¡SD 0.49¡1.19 1.35¡1.88 5.68 2.88 1.06¡1.71
% RN NFCS .3 15 (4%) 58 (15%) 310 (78%) 41 (10%)
BIIP Mean¡SD 1.41¡1.11 2.42¡1.68 5.84¡2.22 2.07¡1.54
% RN BIIP .4 12 (3%) 64 (16%) 314 (79%) 45 (11%)
PIPP* Mean ¡ SD - - 8.06¡3.32 -
% RN PIPP .6 - - 278 (70%) -
SD: Standard Deviation; * The PIPP score was obtained by comparing T2 (Injection) and T0 (rest).
Table 2 - Number (%) of newborns with scores indicative
of pain according to the NFCS, BIIP and PIPP scales at the
time of vitamin K injection.
NFCS BIIP PIPP n (%)
Agreement between the 3 scales 338 (85.1%)
NFCS vs. BIIP vs. PIPP Pain Pain Pain 265 (66.8%)
NFCS vs. BIIP vs. PIPP No Pain No Pain No Pain 73 (18.4%)
Agreement between 2 scales 59 (14.9%)
NFCS vs. BIIP Pain Pain No Pain 37 (9.3%)
No Pain No Pain Pain 8 (2.0%)
NFCS vs. PIPP Pain No Pain Pain 1 (0.3%)
No Pain Pain No Pain 5 (1.3%)
BIIP vs. PIPP No Pain Pain Pain 4 (1.0%)
Pain No Pain No Pain 4 (1.0%)
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significant difference (p,0.001), with a kappa index value of
0.66 (CI 0.58-0.74). There were no differences with respect to
neonatal characteristics between the newborns for whom
the NFCS and PIPP assessments were concordant (n = 344)
and those for whom these assessments were discordant
(n = 73) (Hotelling T2 test: p = 0.86), as shown in Table 3.
Similar results were found when comparing the BIIP and
PIPP; the McNemar test showed a significant difference
(p,0.001) between these scales, with a kappa index of 0.67
(CI 0.59-0.75), but the characteristics of the neonates in the
groups of patients in which BIIP and PIPP were in
agreement (n = 346) or disagreement (n = 51) regarding the
presence/absence of pain at T2 were similar (Table 3;
Hotelling T2 test: p= 0.86).
Finally, the results of the NFCS and BIIP were compared
across the four studied time periods. At T0 (rest), 15 (4%) and
12 (3%) newborns exhibited pain behaviors according to the
NFCS and BIIP, respectively. At T1 (cleansing), these values
were 58 (15%) and 64 (16%), respectively, whereas at T2
(injection), these values increased to 310 (78%) and 314 (79%),
respectively, demonstrating scores indicative of pain. At T3
(recovery), these values were 41 (10%) and 45 (11%),
respectively, also demonstrating scores indicative of pain.
The McNemar test did not reveal any differences between the
two scales (p=0.47) at T2. The kappa index values for the four
study periods are shown in Table 4. A comparison between
the NFCS and the BIIP using generalized linear regression,
based on the Bernoulli distribution, showed a significantmain
effect of time (p=0.0004) but no differences with respect to the
main effect of the scale (p=0.90) or the interaction between
time and the scale (p=0.80). Both scales changed similarly
over time and achieved a maximum score at T2; however,
there were no differences in the pain assessment according to
the scale, and the scores for the NFCS and BIIP scales failed to
change differently over time. Furthermore, there were no
differences with respect to the neonatal characteristics
between the group for whom the NFCS and BIIP assessments
were concordant (n=386) and the group for whom they were
discordant (n= 14) (Hotelling T2 test p= 0.79)
DISCUSSION
The present study compared the NFCS, BIIP and PIPP
scales regarding their ability to assess pain in 400 healthy
term neonates during the first hour of life during an
injection of vitamin K and found that the unidimensional
scales were more sensitive for the detection of pain than the
multidimensional scale. The presence of pain was diag-
nosed 10% more frequently in newborns who were
evaluated using the NFCS or BIIP relative to the number
diagnosed using the PIPP. However, disagreement was
observed between the NFCS and PIPP scales and between
the BIIP and PIPP scales. Both behavioral scales, the NFCS
and BIIP, changed similarly over time and achieved a
Table 3 - Characteristics of the neonates according to the agreement or disagreement between the NFCS, BIIP and PIPP
scales regarding the presence of pain during vitamin K injection (T2).
Agreement Disagreement Bonferroni 95% CI
NFCS vs. BIIP vs. PIPP
Number 338 59
Birthweight (g) 3174¡320 3146¡298 -146.3 to 194.8
Gestational age (weeks) 39.2¡1.3 39.1¡1.2 -0.6 to 0.8
Postnatal age (minutes) 67.5¡45.4 66.3¡46.8 -24.9 to 24.2
Male sex (%) 50 51 -0.05 to 0.07
Cesarean section (%) 65 68 -0.06 to 0.12
NFCS vs. PIPP
Number 344 53
Birthweight (g) 3173¡318 3153¡311 -148.0 to 187.9
Gestational age (weeks) 39.2¡1 39.1¡1.2 -0.6 to 0.8
Postnatal age (minutes) 67.5¡45.2 66.4¡47.9 -23.1 to 25.2
Male sex (%) 65 66 -0.05 to 0.09
Cesarean section (%) 50 47 -0.06 to 0.12
BIIP vs. PIPP
Number 346 51
Birthweight (g) 3173¡319 3149¡301 -154.1 to 202.6
Gestational age (weeks) 39.2¡1.3 39.1¡1.2 -0.6 to 0.8
Postnatal age (minutes) 67.3¡45.2 67.7¡48.1 -26.0 to 25.3
Male sex (%) 50 49 -0.05 to 0.07
Cesarean section (%) 65 67 -0.06 to 0.10
NFCS vs. BIIP
Number 386 14
Birthweight (g) 3171¡318 3111¡238 -253.4 to 373.1
Gestational age (weeks) 39.2¡1.3 38.9¡1.2 -1.0 to 1.6
Postnatal age (minutes) 67.6¡45.7 60.7¡37.7 -38.1 to 51.9
Male sex (%) 49 71 -0.19 to 0.63
Cesarean section (%) 64 79 -0.20 to 0.50
95%CI = 95% confidence interval.
Table 4 - Agreement between the BIIP and NFCS
behavioral scales for the 4 studied time periods.
Pain in
both
No pain
in both
Pain only
in BIIP
Pain only
in NFCS
Kappa
(95% CI)
Rest 11 384 1 4 0.81 (0.64-0.97)
Cleansing 52 330 12 6 0.83 (0.75-0.90)
Injection 305 81 9 5 0.90 (0.85-0.95)
Recovery 37 351 8 4 0.84 (0.76-0.93)
95%CI = 95% confidence interval.
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maximum score at the time of vitamin K injection, and an
almost perfect agreement was observed between the NFCS
and BIIP during the painful stimulus. None of the studied
neonatal characteristics were associated with agreement or
disagreement among the scales.
To our knowledge, this study is the first to evaluate pain
in full-term newborn infants using BIIP at the bedside. The
results of the behavioral scales were similar when cutoff
scores $5 for the BIIP and $4 for the NFCS were used to
indicate the presence of pain. In the literature, only three
papers report the use of the BIIP to evaluate neonatal pain
(20,21,23). In the first two of these studies (20,23), the score
used to indicate the presence of pain was not clear, but an
average BIIP score of 5 was obtained during the procedural
pain stimulus. In the first study (20), 92 infants with a
gestational age between 23 and 32 weeks were analyzed,
and the BIIP scores at baseline, during heel lancing and
during recovery were 1.0¡1.8, 5.3¡2.6 and 1.8¡0.3,
respectively. In the second study (21), 69 infants with a
gestational age between 24 and 32 weeks were studied, and
the BIIP scores at baseline, during heel lancing and during
recovery were 1.0¡1.7, 5.0¡2.6 and 1.6¡2, respectively. In
the same study, the BIIP scores for heel lancing after a
diaper change during the three study periods were 1.0¡1.6,
6.0¡2.7 and 1.5¡2.5, respectively. Therefore, a score of five
or greater was selected as indicative of the presence of pain
during vitamin K injection in full-term neonates. Our results
indicate that this BIIP cutoff is as appropriate as the
previously published NFCS cutoff for the diagnosis of
neonatal pain at the bedside (19). However, additional
studies using different BIIP cutoffs for term and preterm
infants and studies comparing the BIIP to other pain scales
are needed. In addition, studies using imaging exams to
show the location of activated nociceptive pathways should
also be conducted.
The PIPP scale is a multidimensional tool that is
considered by many researchers and clinicians to be the
most suitable scale for the study of acute pain in newborns,
especially in preterm neonates (22,24). However, some
studies have reported dissociation between physiological
and behavioral pain responses (15,25), which reduces the
sensitivity of this multidimensional tool. In a study of
newborns between the post-menstrual ages of 25 and 43
weeks who underwent clinically required heel lancing, pain
was assessed using the PIPP and was correlated with
cortical hemodynamic activity using near-infrared spectro-
scopy (NIRS) (13). The authors observed good correlation
between the behavioral parameters of the PIPP scale and
cortical activity but only moderate correlation between the
physiological variables of the PIPP and cortical activity.
These findings are consistent with the results of other
studies demonstrating that facial expression is the most
specific indicator of pain in neonates (11,12,19). Perhaps the
expression of pain in this age group is predominantly
displayed through facial movements because the nocicep-
tive pathways in newborn infants activate primarily the
nucleus of the brainstem, which is responsible for such
movements, rather than the central control regions that are
linked to the heart and respiratory rates (13).
The NFCS scale is a diagnostic tool that evaluates only
facial movements and enables the differentiation of term
(12) and preterm (19) neonates who are subjected to painful
and tactile, non-painful stimuli. Moreover, this scale is easy
to use at the bedside and has adequate reliability (26). The
BIIP is a behavioral tool that combines an assessment of the
wake/sleep state with two specific hand movements
(finger splay, fisting) and facial actions. This study
demonstrated that this scale can also be assessed in real
time at the bedside. This scale has the ability to identify
pain in premature or critically ill newborns with attenuated
facial expressions (27) and in cases where lower facial
expressions are not readily observable, such as those
infants wearing CPAP masks (21). Studies investigating
neonates have suggested that the hand movements
evaluated in the BIIP scale occur more frequently in in-
fants of a younger gestational age (28), which potentially
indicates a greater sensitivity to pain in this group of
infants (29).
Assuming that the intramuscular injection of vitamin K
is sufficiently painful to be experienced as pain in healthy
term neonates, the pain score will depend on the ability of
the employed tool to measure the nociceptive phenom-
enon. In this context, the results of the present study point
to a greater sensitivity of behavioral tools over multi-
dimensional tools in the assessment of acute pain in
newborn infants. The inclusion of hand movements and
the wake/sleep state did not increase the sensitivity of pain
evaluation in healthy term neonates beyond the use of
facial movements alone. In preterm infants or patients
exposed to multiple painful stimuli, perhaps the attenua-
tion of facial expressiveness and the modulation of pain
responses by the wake/sleep state will reveal some
difference in the sensitivity of pain assessments using the
BIIP or NFCS scales; however, this hypothesis remains to
be tested.
Finally, no association between neonatal characteristics,
including birth weight, gestational age, sex, type of delivery
and postnatal age, and agreement or disagreement between
the different pain scales was detected. No studies in the
literature have evaluated neonatal characteristics as deter-
minants of agreement or disagreement among different pain
assessment tools. The study of healthy infants during the
first hours of life reduces the effects that confounders, such
as early pain exposure and neonatal illness, may have on
pain responses. Thus, the differences observed in the
present study with respect to the ability to identify pain in
newborns are likely due to the intrinsic properties of the
scales themselves.
It is important to note that intramuscular injections are
known to be painful and that analgesia should have been
considered prior to this study. However, when this study
was conducted, vitamin K injections to protect against
hemorrhagic disease in newborns were routinely given
without any analgesia in the delivery room, and there was
much resistance to changing this routine procedure. The
results of this study were shown to hospital administrators
and health professionals, which led to a change in policy,
and now all injections are performed with non-pharmaco-
logical analgesia.
The primary limitation of this research, as well as that of
all studies that have attempted to assess pain in newborns,
is the lack of a gold standard evaluation method to use as a
reference tool. Based on the results of this study, behavioral
scales may be more sensitive than multidimensional tools
for the identification of acute pain during the first hours of
life in healthy term newborn infants.
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